Conference starts in:
8 8
1 1
2 2
2 2
3 3
0 0
4 4

Konstantinos Farsalinos

Dr Konstantinos Farsalinos , Onassis Cardiac Surgery Center, Athens, Greece

Dr Konstantinos Farsalinos is a cardiologist, working as researcher at Onassis Cardiac Surgery Center in Athens-Greece and at Medical Imaging Research Center, University Hospital Gathuisberg in Leuven-Belgium. His main research interests are new modalities in cardiovascular imaging and he has received a scholarship from the Greek Society of Cardiology for research and education in this field. He has studied the effects of smoking on subclinical cardiac dysfunction using new imaging techniques since 2010.

He has been actively performing research on electronic cigarettes since 2011 as a principle investigator, in both clinical and laboratory level. Examples of his work include the first study on the cytotoxic effects of electronic cigarette vapor on cultured cells and the immediate effects of electronic cigarettes used on cardiac function and coronary circulation. He has presented his research in major international scientific congresses and has published more than 15 studies and letters about e-cigarettes in peer-reviewed medical journals.

GFN'14 photo highlights

GFN Twitter Feed

GFN Scholarship Fund

Donate any amount to help unwaged/low income advocates and enthusiasts to attend the GFN 2015.
Every euro donated will be used to cover delegate fees. Every euro that you donate, we will match with with another 0.5 euro!

Supporting organisations:


ECIG-INTEL   erf logo
SUEP 150    LIAF 64

ma cigarette

Media Partners:

psdn-naukowi NSP-LOGO-light-100px

IJDP 64 vapourtrails-tv

The conference is supported from participant registration fees. It does not receive funding by way of sponsorship or exhibition fees from any company making nicotine products including tobacco, electronic cigarette or pharmaceutical companies. We will accept sponsorship from non-industry organisations. The supporting organisations for the conference are shown on the website

The event is open to all and there are no restrictions on who can attend and participate in questions and discussion. The ethos of the event is to encourage debate across sectors. It attracts academics, policy makers, parliamentarians, regulators, consumers, advocacy groups and those involved in manufacturing or distributing nicotine products.